Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.8, pp.897-902, 1994. ,
DOI : 10.1136/jnnp.57.8.897
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis, Human Molecular Genetics, vol.25, issue.Pt 6, pp.2813-2837, 2006. ,
DOI : 10.1002/gepi.10258
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-69, 1997. ,
DOI : 10.1093/brain/120.11.2059
Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis, Journal of Neurology, vol.50, issue.Pt 3, pp.20-25, 2007. ,
DOI : 10.1212/WNL.50.5.1282
Relevance of immunological variables in neuroborreliosis and multiple sclerosis, Acta Neurologica Scandinavica, vol.116, issue.2, pp.97-102, 2005. ,
DOI : 10.1212/WNL.51.3.885
Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel, Genes & Immunity, vol.33, issue.5, pp.423-454, 2010. ,
DOI : 10.1198/106186002760180590
CD5, Annual Review of Immunology, vol.20, issue.1, pp.253-300, 2001. ,
DOI : 10.1146/annurev.immunol.20.100301.064833
Role of natural and immune IgM antibodies in immune responses, Molecular Immunology, vol.37, issue.18, pp.1141-1150, 2000. ,
DOI : 10.1016/S0161-5890(01)00025-6
Lymphocyte subsets in multiple sclerosis A study with two-colour fluorescence analysis, Journal of the Neurological Sciences, vol.139, issue.1 ,
DOI : 10.1016/0022-510X(96)00030-5
Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands. Mult Scler, pp.810-815, 2010. ,
The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands, Journal of Neuroimmunology, vol.226, issue.1-2, pp.143-149, 2010. ,
DOI : 10.1016/j.jneuroim.2010.05.032
Homogeneity of active demyelinating lesions in established multiple sclerosis, Annals of Neurology, vol.143, issue.pt 4 ,
DOI : 10.1042/bj2640001
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis, Brain, vol.128, issue.7, pp.1667-76, 2005. ,
DOI : 10.1093/brain/awh486
The Many Roles of Chemokines and Chemokine Receptors in Inflammation, New England Journal of Medicine, vol.354, issue.6, pp.610-631, 2006. ,
DOI : 10.1056/NEJMra052723
Plasma cells in cerebrospinal fluid and multiple sclerosis: diagnostic yield and clinicobiological correlations, Acta Neurologica Scandinavica, vol.13, issue.No 599, pp.432-440, 1986. ,
DOI : 10.1212/WNL.33.5.611
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis, Proceedings of the National Academy of Sciences, vol.86, issue.1, pp.11064-11073, 2004. ,
DOI : 10.1016/S0165-5728(98)00002-2
Oligoclonal bands and antibody responses in Multiple Sclerosis, Journal of Neurology, vol.249, issue.4, pp.375-89, 2002. ,
DOI : 10.1007/s004150200026
The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up study, Neurology, vol.60, issue.7, pp.1163-1169, 2003. ,
DOI : 10.1212/01.WNL.0000055864.08740.CB
Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France, Journal of Neurology, vol.10, issue.10, p.1370, 2007. ,
DOI : 10.1212/01.wnl.0000188880.17038.1d
Multiple Sclerosis ??? The Plaque and Its Pathogenesis, New England Journal of Medicine, vol.354, issue.9, pp.942-55, 2006. ,
DOI : 10.1056/NEJMra052130
Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment, European Journal of Neurology, vol.12, issue.3, 2009. ,
DOI : 10.1159/000103643
The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion, Brain, vol.120, issue.8, pp.1461-83, 1997. ,
DOI : 10.1093/brain/120.8.1461
Identification of autoantibodies associated with myelin damage in multiple sclerosis, Nature Medicine, vol.63, issue.2, pp.170-175, 1999. ,
DOI : 10.1046/j.1471-4159.1994.63062353.x
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab, Annals of Neurology, vol.14, issue.pt 8, pp.83-92, 2010. ,
DOI : 10.1177/1352458507082061
B-Cell Depletion with Rituximab in Relapsing???Remitting Multiple Sclerosis, New England Journal of Medicine, vol.358, issue.7, pp.676-88, 2008. ,
DOI : 10.1056/NEJMoa0706383
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis, Brain, vol.80, issue.9, pp.2755-71, 2011. ,
DOI : 10.1136/jnnp.2008.154906
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: Commentary, Multiple Sclerosis Journal, vol.19, issue.6, pp.719-739, 2013. ,
DOI : 10.1136/jnnp.2008.150896
Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct, Neurology, vol.67, issue.6, pp.1062-1066, 2006. ,
DOI : 10.1212/01.wnl.0000237343.93389.35
Traduction de la 7 ème édition anglaise par Pierre L. Masson, 2009. ,
Cerebrospinal Fluid IgM Index Correlates with Cranial MRI Lesion Load in Patients with Multiple Sclerosis, European Neurology, vol.58, issue.2, pp.90-95, 2007. ,
DOI : 10.1159/000103643
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial, The Lancet, vol.378, issue.9805, pp.1779-87, 2011. ,
DOI : 10.1016/S0140-6736(11)61649-8
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis, Multiple Sclerosis Journal, vol.19, issue.8 ,
DOI : 10.1212/01.WNL.0000151852.15294.CB
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course, Multiple Sclerosis Journal, vol.17, issue.3, pp.335-378, 2010. ,
DOI : 10.1001/archneurol.2010.99
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation, Journal of Neuroinflammation, vol.76, issue.1, pp.93-103, 2012. ,
DOI : 10.1212/WNL.0b013e3182143564
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma, The Journal of Experimental Medicine, vol.161, issue.2, pp.195-200, 2005. ,
DOI : 10.1002/jnr.490320405
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment, Brain, vol.129, issue.1, pp.200-211, 2005. ,
DOI : 10.1038/nn1127
B cells and antibodies in multiple sclerosis pathogenesis and therapy, Nature Reviews Neurology, vol.25, issue.11, pp.613-636, 2009. ,
DOI : 10.1016/j.jaut.2005.08.004
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One, 2008. ,
In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin, Acta Neuropathologica, vol.1, issue.Suppl, pp.297-306, 1981. ,
DOI : 10.1007/BF00690994
Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.67, issue.5, pp.1900-1913, 2010. ,
DOI : 10.1212/01.wnl.0000234064.17156.03
Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility, Proceedings of the National Academy of Sciences, vol.52, issue.3, pp.7542-7549, 2009. ,
DOI : 10.1017/S0317167100034041
URL : http://www.pnas.org/content/106/18/7542.full.pdf
Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients, Journal of Neuroimmunology, vol.194, issue.1-2, pp.153-64, 2008. ,
DOI : 10.1016/j.jneuroim.2007.11.007
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness, Journal of Neuroimmunology, vol.180, issue.1-2, pp.17-28, 2006. ,
DOI : 10.1016/j.jneuroim.2006.07.006
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression, Multiple Sclerosis Journal, vol.29, issue.5, 2013. ,
DOI : 10.1212/WNL.0b013e3182190f74
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis, Brain, vol.182, issue.2, pp.534-575, 2011. ,
DOI : 10.4049/jimmunol.0803424
Inflammatory Cortical Demyelination in Early Multiple Sclerosis, New England Journal of Medicine, vol.365, issue.23, pp.2188-97, 1056. ,
DOI : 10.1056/NEJMoa1100648
Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG, Clinica Chimica Acta, vol.187, issue.3, pp.297-308, 1990. ,
DOI : 10.1016/0009-8981(90)90115-9
10 Most Commonly Asked Questions About Cerebrospinal Fluid Characteristics in Demyelinating Disorders of the Central Nervous System, The Neurologist, vol.14, issue.1, pp.60-65, 2008. ,
DOI : 10.1097/NRL.0b013e31815ac523
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation, Annals of Neurology, vol.64, issue.6, pp.880-92, 2006. ,
DOI : 10.1212/01.WNL.0000159399.81861.D5
International Multiple Sclerosis Genetics Consortium Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles, PLoS One, vol.8, issue.3, 2013. ,
Clinically isolated syndromes, The Lancet Neurology, vol.11, issue.2, pp.157-69 ,
DOI : 10.1016/S1474-4422(11)70274-5
URL : https://hal.archives-ouvertes.fr/hal-00552764
B cells expressing CD5 are increased in cerebrospinal fluidof patients with multiple sclerosis, Clinical & Experimental Immunology, vol.17, issue.Suppl. 28, pp.21-28, 1990. ,
DOI : 10.3109/00365517709091496
THE PREDICTIVE VALUE OF CEREBROSPINAL FLUID ELECTROPHORESIS IN ???POSSIBLE??? MULTIPLE SCLEROSIS, Brain, vol.106, issue.4, pp.809-825, 1983. ,
DOI : 10.1093/brain/106.4.809
Natalizumab effects on immune cell responses in multiple sclerosis, Annals of Neurology, vol.182, issue.5, pp.748-54, 2006. ,
DOI : 10.4049/jimmunol.168.1.499
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin, Journal of Neuroimmunology, vol.233, issue.1-2, pp.245-253, 2011. ,
DOI : 10.1016/j.jneuroim.2011.01.010
Protective and therapeutic role for ??B-crystallin in autoimmune demyelination, Nature, vol.95, issue.7152, pp.474-483, 2007. ,
DOI : 10.4049/jimmunol.164.8.4359
Soluble silk-like organic matrix in the nacreous layer of the bivalve Pinctada maxima, European Journal of Biochemistry, vol.132, issue.20 ,
DOI : 10.1016/S1096-4959(01)00524-3
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.8, pp.953-958, 2006. ,
DOI : 10.1136/jnnp.2005.086116
Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, pp.840-846, 2005. ,
DOI : 10.1212/WNL.53.6.1184
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011. ,
DOI : 10.1002/ana.21464
Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active ??4??1-fibronectin receptors upon B cell activation, European Journal of Immunology, vol.249, issue.10, pp.2437-2482, 1991. ,
DOI : 10.1007/978-3-642-71272-2_3
The epidemiology of multiple sclerosis in Europe, European Journal of Neurology, vol.51, issue.2, pp.700-722, 2006. ,
DOI : 10.1093/heapol/16.3.326
OPTIC NEURITIS: STUDIES ON THE CEREBROSPINAL FLUID IN RELATION TO CLINICAL COURSE IN 61 PATIENTS, Acta Neurologica Scandinavica, vol.58, issue.Suppl. 124, pp.167-78, 1975. ,
DOI : 10.1001/archneur.1969.00480080032003
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS, Neurology, vol.78, issue.24, pp.1986-91, 2012. ,
DOI : 10.1212/WNL.0b013e318259e1b2
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis, New England Journal of Medicine, vol.367, issue.2, pp.115-138, 1056. ,
DOI : 10.1056/NEJMoa1110740
The Inheritance of Resistance Alleles in Multiple Sclerosis, PLoS Genetics, vol.26, issue.9, pp.1607-1620, 2007. ,
DOI : 1098-2272(2004)026[0186:POPAFG]2.0.CO;2
Natalizumab for Multiple Sclerosis, New England Journal of Medicine, vol.356, issue.25, pp.2622-2631, 2007. ,
DOI : 10.1056/NEJMct071462
Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system, Clinica Chimica Acta, vol.163, issue.3, pp.319-347, 1987. ,
DOI : 10.1016/0009-8981(87)90250-6
Flow rate of cerebrospinal fluid (CSF) ??? A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases, Journal of the Neurological Sciences, vol.122, issue.2, pp.189-203, 1994. ,
DOI : 10.1016/0022-510X(94)90298-4
Dynamics of brain-derived proteins in cerebrospinal fluid, Clinica Chimica Acta, vol.310, issue.2, pp.173-86, 2001. ,
DOI : 10.1016/S0009-8981(01)00573-3
Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and sourcerelated dynamics, Restor Neurol Neurosci, vol.21, pp.3-479, 2003. ,
Reporting Cerebrospinal Fluid Data: Knowledge Base and Interpretation Software, Clinical Chemistry and Laboratory Medicine, vol.21, issue.4, pp.324-356, 2001. ,
DOI : 10.1515/CCLM.2000.106
URL : http://www.horeiber.de/pdf/17.pdf
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs, Journal of the Neurological Sciences, vol.184, issue.2, pp.101-123, 2001. ,
DOI : 10.1016/S0022-510X(00)00501-3
Mapping regional grey and white matter atrophy in relapsing???remitting multiple sclerosis, Multiple Sclerosis Journal, vol.18, issue.7, pp.1027-1064, 2012. ,
DOI : 10.1148/radiol.10100326
Inhibition of CNS myelin developmentin vivo by implantation of anti-GalC hybridoma cells, Journal of Neurocytology, vol.34, issue.11, pp.699-707, 1994. ,
DOI : 10.1007/BF01181644
Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma, Journal of Neurocytology, vol.32, issue.3, pp.4-5397, 1999. ,
DOI : 10.1023/B:NEUR.0000010085.91976.a6
Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma, Journal of Neurocytology, vol.32, issue.3 ,
DOI : 10.1023/B:NEUR.0000010085.91976.a6
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation, Multiple Sclerosis Journal, vol.74, issue.1, pp.59-68, 2012. ,
DOI : 10.1007/s00415-009-5200-9
Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up, Brain, vol.116, issue.1, pp.117-151, 1993. ,
DOI : 10.1093/brain/116.1.117
Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis, Annals of Neurology, vol.278, issue.6, pp.980-983, 1998. ,
DOI : 10.1212/WNL.46.4.907
MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS, Neurology, vol.56, issue.8, pp.1084-1093, 2001. ,
DOI : 10.1212/WNL.56.8.1084
Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event, European Journal of Neurology, vol.258, issue.8, pp.907-918, 2007. ,
DOI : 10.1191/1352458505ms1187sr
Detection of Ectopic B-cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis, Brain Pathology, vol.100, issue.2, pp.164-74, 2004. ,
DOI : 10.1172/JCI119622
The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis, Annals of Neurology, vol.43, issue.2, pp.147-51, 1991. ,
DOI : 10.1007/978-1-4613-0777-8_15
Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit, Neurology, vol.58, issue.9, pp.1372-81, 2002. ,
DOI : 10.1212/WNL.58.9.1372
Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases, Journal of Neuroimmunology, vol.33, issue.1, pp.63-72, 1991. ,
DOI : 10.1016/0165-5728(91)90035-6
Age-related disability in multiple sclerosis, Annals of Neurology, vol.67, issue.4, pp.475-80, 2002. ,
DOI : 10.1136/jnnp.67.2.148
A sensitive and reproducible method for the detection of oligoclonal IgM bands, Journal of Immunological Methods, vol.258, issue.1-2, pp.151-156, 2001. ,
DOI : 10.1016/S0022-1759(01)00492-6
Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS, Neurology, vol.58, issue.5, pp.824-830, 2002. ,
DOI : 10.1212/WNL.58.5.824
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS, Neurology, vol.59, issue.4, pp.555-564, 2002. ,
DOI : 10.1212/WNL.59.4.555
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis, Annals of Neurology, vol.5, issue.2, pp.222-228, 2003. ,
DOI : 10.1002/ana.410440621
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS, Journal of Clinical Investigation, vol.115, issue.1, pp.187-94, 2005. ,
DOI : 10.1172/JCI22833
Influence of oligoclonal IgM specificity in multiple sclerosis disease course, Multiple Sclerosis Journal, vol.14, issue.2, pp.183-190, 2007. ,
DOI : 10.1038/5532
CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis, Journal of Neuroimmunology, vol.211, issue.1-2, 2009. ,
DOI : 10.1016/j.jneuroim.2009.03.003
Immunological mechanisms that REVUES RÉFÉRENCES 1 Suppressor T cells: they're back and critical for regulation of autoimmunity, Immunol Rev, vol.182, pp.149-63, 2001. ,
FOXP3+ regulatory T cells in the human immune system, Nature Reviews Immunology, vol.34, issue.7, pp.490-500, 2010. ,
DOI : 10.4049/jimmunol.172.10.5967
Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells, Nature Immunology, vol.173, issue.4, pp.351-359, 2007. ,
DOI : 10.1186/1471-2172-7-6
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation, Journal of Experimental Medicine, vol.184, issue.2, pp.387-96, 1996. ,
DOI : 10.1084/jem.184.2.387
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of selftolerance causes various autoimmune diseases, J Immunol, vol.155, pp.1151-64, 1995. ,
Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-61, 2003. ,
DOI : 10.1126/science.1079490
Phenotypical and functional specialization of FOXP3+ regulatory T cells, Nature Reviews Immunology, vol.177, issue.2, pp.119-149, 2011. ,
DOI : 10.4049/jimmunol.177.10.6983
T reg cells, The Journal of Experimental Medicine, vol.376, issue.7, pp.1701-1712, 2006. ,
DOI : 10.1016/S0092-8674(04)00127-8
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor, Immunity, vol.30, issue.6, pp.899-911, 2009. ,
DOI : 10.1016/j.immuni.2009.03.019
GARP (LRRC32) is essential for the surface expression of latent TGF-?? on platelets and activated FOXP3+ regulatory T cells, Proceedings of the National Academy of Sciences, vol.9, issue.14, pp.13445-50, 2009. ,
DOI : 10.1016/S0002-9440(10)63458-X
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice, Nature Immunology, vol.7, issue.2, pp.191-198, 2007. ,
DOI : 10.1038/ni1289
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2R??-Deficient Mice, Immunity, vol.17, issue.2, pp.167-78, 2002. ,
DOI : 10.1016/S1074-7613(02)00367-9
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases, Nature Reviews Immunology, vol.3, issue.12, pp.849-59, 2010. ,
DOI : 10.4049/jimmunol.172.6.3580
Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice, Journal of Clinical Investigation, vol.119, pp.2648-62, 2009. ,
DOI : 10.1172/JCI36628DS1
URL : https://hal.archives-ouvertes.fr/hal-00420216
CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation, Science Translational Medicine, vol.25, issue.5, pp.41-52, 2010. ,
DOI : 10.1200/JCO.2006.09.2403
Regulatory T cells in tumor immunity, International Journal of Cancer, vol.27, pp.759-67, 2010. ,
DOI : 10.4049/jimmunol.176.11.6434
Human FOXP3+ Regulatory T Cells in Transplantation, American Journal of Transplantation, vol.9, issue.8, pp.1719-1743, 2009. ,
DOI : 10.4049/jimmunol.178.12.7667
Immunoregulatory T Cells, The Journal of Experimental Medicine, vol.141, issue.3, pp.401-407, 2002. ,
DOI : 10.1016/S0167-5699(98)01420-0
URL : https://hal.archives-ouvertes.fr/hal-00018382
Mini-review: Regulatory T cells and infection: suppression revisited, European Journal of Immunology, vol.34, issue.2, pp.306-318, 2004. ,
DOI : 10.1002/eji.200324578
Role of Treg in immune regulation of allergic diseases, European Journal of Immunology, vol.206, issue.5, pp.1232-1272, 2010. ,
DOI : 10.4049/jimmunol.172.5.3252
The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, vol.24, issue.7169, pp.566-575, 2007. ,
DOI : 10.4049/jimmunol.170.8.3939
Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression, Biochemical and Biophysical Research Communications, vol.327, issue.4, pp.1066-71, 2005. ,
DOI : 10.1016/j.bbrc.2004.12.106
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, The Journal of Experimental Medicine, vol.261, issue.6 ,
DOI : 10.1074/jbc.275.3.2057
Cyclic adenosine monophosphate is a key component of regulatory T cell???mediated suppression, The Journal of Experimental Medicine, vol.69, issue.6, pp.1303-1313, 2007. ,
DOI : 10.1084/jem.20041538
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells, The Journal of Immunology, vol.167, issue.3, pp.1137-1177, 2001. ,
DOI : 10.4049/jimmunol.167.3.1137
Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death, Immunity, vol.21, issue.4, pp.589-601, 2004. ,
DOI : 10.1016/j.immuni.2004.09.002
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells, The Journal of Experimental Medicine, vol.207, issue.9 ,
DOI : 10.1038/ni.1774
Interleukin???10???secreting type 1 regulatory T cells in rodents and humans, Immunological Reviews, vol.169, issue.1, pp.28-50, 2006. ,
DOI : 10.1067/mai.2003.1570
Phenotypic and Functional Differences Between Human CD4+CD25+ and Type 1 Regulatory T Cells, Curr Top Microbiol Immunol, vol.293, pp.303-329, 2005. ,
DOI : 10.1007/3-540-27702-1_14
IL-10-producing type 1 regulatory T cells and allergy, Cell Mol Immunol, vol.4, pp.269-75, 2007. ,
Siri m/s n° 8-9, p.2012 ,
regulatory T cells restore normoglycemia in diabetic NOD mice, The Journal of Experimental Medicine, vol.344, issue.1, pp.191-201, 2007. ,
DOI : 10.1172/JCI23961
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus, The Journal of Immunology, vol.175, issue.12, pp.8392-400, 2005. ,
DOI : 10.4049/jimmunol.175.12.8392
Suppression of Disease in New Zealand Black/New Zealand White Lupus-Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells, The Journal of Immunology, vol.177, issue.3, pp.1451-1460, 2006. ,
DOI : 10.4049/jimmunol.177.3.1451
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis, The Journal of Immunology, vol.177, issue.9, pp.5852-60, 2006. ,
DOI : 10.4049/jimmunol.177.9.5852
Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells, Arthritis & Rheumatism, vol.104, issue.7, pp.2212-2233, 2005. ,
DOI : 10.4049/jimmunol.169.9.4712
IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells, International Immunology, vol.16, issue.2, pp.249-56, 2004. ,
DOI : 10.1093/intimm/dxh029
Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice, The Journal of Immunology, vol.175, issue.5, pp.3053-3062, 2005. ,
DOI : 10.4049/jimmunol.175.5.3053
In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures, Blood, vol.104, issue.2, pp.453-61, 2004. ,
DOI : 10.1182/blood-2004-01-0151
T Suppressor Cell Clones Produce Transforming Growth Factor ??, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells, The Journal of Experimental Medicine, vol.44, issue.10, pp.1335-1381, 2002. ,
DOI : 10.1084/jem.20020642
In Vitro???expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes, The Journal of Experimental Medicine, vol.161, issue.11, pp.1455-65, 2004. ,
DOI : 10.1016/S1521-6616(02)00017-7
Therapeutic potential of self-antigen-specific CD4+CD25+ regulatory T cells selectedin vitro from a polyclonal repertoire, European Journal of Immunology, vol.172, issue.4, pp.817-844, 2006. ,
DOI : 10.4049/jimmunol.172.10.6003
Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo, Blood, vol.102, issue.6, pp.2180-2186, 2003. ,
DOI : 10.1182/blood-2003-04-1164
Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients, The Journal of Immunology, vol.177, issue.12, pp.8338-8385, 2006. ,
DOI : 10.4049/jimmunol.177.12.8338
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma, Gut, vol.50, issue.2, pp.191-196, 2002. ,
DOI : 10.1136/gut.50.2.191
T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)??? and Th2-inducing Cytokines, The Journal of Experimental Medicine, vol.153, issue.5, pp.603-619, 2002. ,
DOI : 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7
URL : http://jem.rupress.org/content/jem/195/5/603.full.pdf
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, vol.389, issue.6652, pp.737-779, 1997. ,
DOI : 10.1007/978-3-662-22038-2_16
Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo, Immunity, vol.18, issue.5, pp.605-622, 2003. ,
DOI : 10.1016/S1074-7613(03)00113-4
Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy, Haematologica, vol.95, issue.12, pp.2134-2177, 2010. ,
DOI : 10.3324/haematol.2010.025825
Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases, International Immunopharmacology, vol.9, issue.5, pp.609-622, 2009. ,
DOI : 10.1016/j.intimp.2009.01.032
Plasticity of CD4+ T Cell Lineage Differentiation, Immunity, vol.30, issue.5, pp.646-55, 2009. ,
DOI : 10.1016/j.immuni.2009.05.001
T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity, Proceedings of the National Academy of Sciences, vol.106, issue.6, pp.1903-1911, 2009. ,
DOI : 10.1073/pnas.0702004104
URL : https://hal.archives-ouvertes.fr/hal-00407810
73 CREB/ATF-Dependent T-cell Receptor-Induced FoxP3 Gene Expression: A Role for DNA Methylation, Cytokine, vol.39, issue.1, pp.1543-51, 2007. ,
DOI : 10.1016/j.cyto.2007.07.078
Deacetylase inhibition promotes the generation and function of regulatory T cells, Nature Medicine, vol.90, issue.11, pp.1299-307, 2007. ,
DOI : 10.4049/jimmunol.166.2.973
Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes, Blood, vol.105, issue.5, pp.2090-2092, 2005. ,
DOI : 10.1182/blood-2004-09-3579
Highly efficient endogenous human gene correction using designed zinc-finger nucleases, Nature, vol.100, issue.7042, pp.646-51, 2005. ,
DOI : 10.1073/pnas.2035056100
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes, Immunity, vol.12, issue.4, pp.431-471, 2000. ,
DOI : 10.1016/S1074-7613(00)80195-8
Rhumatisme articulaire aigu, m??decine/sciences, vol.134, issue.6-7, pp.633-641, 2012. ,
DOI : 10.1016/j.ijcard.2008.12.110
URL : http://www.medecinesciences.org/articles/medsci/pdf/2012/08/medsci2012286-7p633.pdf